Antiviral Drugs Market Size, Share, Growth Analysis, By Type(Branded Drugs and Generic Drugs.), By Application(HIV/AIDS, Hepatitis, Influenza, Herpes and Other Indications.), By Region - Industry Forecast 2024-2031

Antiviral Drugs Market size was valued at USD 36.1 billion in 2021 and is poised to grow from USD 37.26 billion in 2022 to USD 47.93 billion by 2030, growing at a CAGR of 3.2% during the forecast period (2023-2030).

The global antiviral drugs market is experiencing substantial growth due to several key factors. Firstly, the increasing incidence of viral infections, particularly HIV/AIDS, hepatitis B and C, and influenza, has created a significant demand for effective antiviral therapies. Pharmaceutical companies are investing in research and development activities to develop novel antiviral drugs with enhanced efficacy, reduced side effects, and improved patient compliance. The discovery of new drug targets and the development of innovative therapeutic approaches have expanded the range of treatment options available to healthcare professionals. Additionally, the growing awareness about viral infections and the importance of early diagnosis and treatment has fueled the demand for antiviral drugs. Governments and healthcare organizations worldwide are increasingly focusing on prevention and control measures to reduce the burden of viral diseases, which has further boosted the market. Moreover, favorable government initiatives and funding for research and development activities in the field of antiviral drugs have stimulated market growth. Public-private partnerships and collaborations have played a crucial role in advancing antiviral drug discovery and ensuring their accessibility and affordability.

Lastly, the rising investment by pharmaceutical companies in the development of antiviral drugs, coupled with the increasing number of clinical trials, has significantly contributed to market expansion. These companies are investing in research and development to address the unmet medical needs associated with viral infections and to capitalize on the market potential. Overall, the global market is witnessing steady growth, driven by the increasing prevalence of viral infections, advancements in medical research, growing awareness, government initiatives, and pharmaceutical investments.

US Antiviral Drugs Market is poised to grow at a sustainable CAGR for the next forecast year.